Recurrence of hepatitis C after liver transplantation.
Cirrhosis due to hepatitis C is currently the most common indication for liver transplantation in the United States as well as in Europe. The prognosis for patients transplanted due to hepatitis C has changed over the years. Today there is growing concern as to the prognosis of these patients and how we should treat them. This is an overview of the developments in this field concerning treatment of recurrence and the role of preemptive treatment.
Friman
S
S
Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden. styrbjorn.friman@surgery.gu.se
D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007372:Interferons / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology / Q000706:statistics & numerical data*; D011379:Prognosis; D012008:Recurrence; D012189:Retrospective Studies; D012254:Ribavirin / Q000627:therapeutic use; D018570:Risk Assessment
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons